Post hoc analysis of Protocol AC (284 patients with DME): similar proportions achieved absence of DME with aflibercept vs bevacizumab-first (81.4% vs 71.9%, P=0.068), but aflibercept achieved it sooner (mean 16.2 vs 30.8 weeks).
Secondary analysisn = 284 patients
Ni et al. Eyes Achieving Absence of Diabetic Macular Edema and Very Good Vision: A Post Hoc Analysis of Diabetic Retinopathy Clinical Research Network Protocol AC